The Anti-Fibrotic Effects of CG-745, an HDAC Inhibitor, in Bleomycin and PHMG-Induced Mouse Models

Renoprotective Effect of the Histone Deacetylase Inhibitor CG200745 in DOCA-Salt Hypertensive Rats

(2019) Eun Bae et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Histone deacetylases in cardiovascular and metabolic diseases

(2019) Rushita A. Bagchi et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Protective effects of Rosavin on bleomycin-induced pulmonary fibrosis via suppressing fibrotic and inflammatory signaling pathways in mice

(2019) Xiaobin Xin et al.   BIOMEDICINE & PHARMACOTHERAPY

Idiopathic Pulmonary Fibrosis

(2018) David J. Lederer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Histone deacetylase inhibitor, CG200745 attenuates renal fibrosis in obstructive kidney disease

(2018) Hong Sang Choi et al.   Scientific Reports

Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis

(2018) Martina Korfei et al.   PLoS One

Types of household humidifier disinfectant and associated risk of lung injury (HDLI) in South Korea

(2017) Dong-Uk Park et al.   SCIENCE OF THE TOTAL ENVIRONMENT

The attenuation of renal fibrosis by histone deacetylase inhibitors is associated with the plasticity of FOXP3+IL-17+ T cells

(2017) Wen-Pyng Wu et al.   BMC Nephrology

Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway

(2017) Shigeki Saito et al.   PLoS One

A novel HDAC inhibitor, CG200745, inhibits pancreatic cancer cell growth and overcomes gemcitabine resistance

(2017) Hee Seung Lee et al.   Scientific Reports

HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases

(2016) Elizabeth E. Hull et al.   Biomed Research International

Idiopathic Pulmonary Fibrosis in United States Automated Claims. Incidence, Prevalence, and Algorithm Validation

(2015) Daina B. Esposito et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline

(2015) Ganesh Raghu et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Polyhexamethylene guanidine phosphate aerosol particles induce pulmonary inflammatory and fibrotic responses

(2015) Ha Ryong Kim et al.   ARCHIVES OF TOXICOLOGY

Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis

(2015) Martina Korfei et al.   THORAX

A new histone deacetylase inhibitor improves liver fibrosis in BDL rats through suppression of hepatic stellate cells

(2014) Ki Cheong Park et al.   BRITISH JOURNAL OF PHARMACOLOGY

Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice

(2014) Y. Y. Sanders et al.   EUROPEAN RESPIRATORY JOURNAL

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

(2014) Talmadge E. King et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

(2014) Luca Richeldi et al.   NEW ENGLAND JOURNAL OF MEDICINE

A cluster of lung injury cases associated with home humidifier use: an epidemiological investigation

(2014) Hwa Jung Kim et al.   THORAX

Humidifier Disinfectant-Associated Children’s Interstitial Lung Disease

(2013) Kyung Won Kim et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Histone modifications are responsible for decreased Fas expression and apoptosis resistance in fibrotic lung fibroblasts

(2013) S K Huang et al.   Cell Death & Disease

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

(2011) Paul W Noble et al.   LANCET

Strategies for treating idiopathic pulmonary fibrosis

(2010) R. M. du Bois   NATURE REVIEWS DRUG DISCOVERY

Abrogation of TGF-β1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition

(2009) Weichao Guo et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY